Servicios Personalizados
Revista
Articulo
Artículo en XML
Referencias del artículo
Traducción automática
Enviar artículo por emailIndicadores
Citado por SciELO 
Accesos
Links relacionados
Similares en
SciELO
Compartir
Permalink
Archivos de cardiología de México
versión On-line ISSN 1665-1731versión impresa ISSN 1405-9940
Resumen
GARCIA-GUTIERREZ, Juan C. et al. Experience with the use of the bio-active stent coated with titanium nitric oxide compared with zotarolimus-eluting stent: experience of a unit medical high specialty. Arch. Cardiol. Méx. [online]. 2016, vol.86, n.1, pp.18-25. ISSN 1665-1731. https://doi.org/10.1016/j.acmx.2015.06.001.
The use of coronary stents in coronary angioplasty has evolved dramatically in its design, type materials, polymers, and a variety of drugs, the use of coronary stents covered nitric oxide have shown satisfactory results in practice, however compared to the results reported drug-eluting stents, there is little information.
Objectives:
The aim of this study was to compare clinical outcomes of a stainless steel stent Bioactive nitric oxide coated titanium (BAS) and a drug-eluting stent zotarolimus (DES) in daily clinical practice.
Methods:
A retrospective, analytical, descriptive and comparative study aimed at evaluating the safety and efficacy of two devices with different characteristics in our population. The primary endpoints were: death, acute infarction (AMI), and re intervention injury Treated (RLT).
Results:
A total of 759 patients were included in the study which was performed angioplasty to a single vessel. Were divided into two arms 382 with DES and 377 patients with BAS, the one year follow up was carried in 95%. After this follow-up period, primary points (cardiovascular death, myocardial infarction, TLR and stent thrombosis) for arm DES vs BAS; 9.5% vs 8.5% P = NS but with shorter periods of dual antiplatelet therapy for arm BAS 6.9 ± 4.1 vs 11.1 ± 2.5 months DES P = .0001. The results were independent of the clinical syndrome of presentation.
Conclusions:
After one year of follow no statistically significant difference in major clinical events, there was a trend in favour of BAS vs SM with respect to revascularization of the target lesion without reaching statistical significance.
Palabras llave : Angioplasty; Drug eluting stent; Stent thrombosis; Bioactive stenting; México.
